Edgen Stock·Dec 09 2025, 23:59Back
Pfizer Challenges Rivals With Chinese GLP-1 Deal
Edgen Stock·Dec 09 2025, 23:59
[1] China's Ascletis reports 7.7% weight loss for oral GLP-1 contender in US phase 2 study - Fierce Biotech (https://www.fiercebiotech.com/biotech/chinas- ...)[2] LLY, PFE: Eli Lilly’s Mounjaro, Pfizer’s Cancer Drug Added to China’s State Insurance List - TipRanks (https://www.tipranks.com/news/lly-pfe-eli-lil ...)[3] Eli Lilly's Mounjaro added to China's state insurance list for diabetes treatment - Reuters (https://www.reuters.com/business/healthcare-p ...)
